The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

British Journal of Cancer

Volumn 83, Issue 4, 2000, Pages 463-466

  Vazina, A ^a   Baniel, J ^a   Yaacobi, Y ^c   Shtriker, A ^c   Engelstein, D ^a   Leibovitz, I ^b   Zehavi, M ^c   Sidi, A A ^c   Ramon, Y ^b   Tischler, T ^c   Livne, P M ^a   Friedman, E ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; FAMILY HISTORY; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; ISRAEL; JEW; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0033943282     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1249     Document Type: Article

References (30)

1. Abeliovich D, Kaduri L, Lerer I et al (1997) The founder mutation 185delAG and 5382insC in BRCA1 and 617delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer among Ashkenazi women Am J Hum Genet 60: 505-514
2. Anderson DE and Badzioch MD (1993) Familial effect of prostate and other cancers on lifetime breast cancer risk. Breast Cancer Res Treat 28: 107-113
3. Arason A, Barkadottier RB and Egilsson V (1993) Linkage analysis of chromosome 17 markers and breast ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet 52: 711-717
4. Bar-Sade RB, Kruglikova A, Modan B et al (1998) The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum Mol Genet 7: 801-805
5. Briana JW, Emma J, Xiao LZ et al (1996) Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer. J Urol 155: 720-725
6. Carter BS, Beatty TH, Steinberg GD, Childs B and Walsh PC (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89. 3367-3371
7. Deubler DA, Williams BJ, Zhu XL, Steele MR, Rohr LR, Jensen JC, Stephenson RA, Changus JE, Miller GJ, Becich MJ and Brothman AR (1997) Allelic loss detected on chromosomes 8, 10 and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin-embedded prostate tumors. Am J Pathol 150: 841-850
8. Easton DF, Ford D, Bishop DT and the Breast Cancer Linkage Consortium (1995) Risks of cancer in BRCA1 mutation carriers. Am J Hum Genet 56: 265-271
9. Easton DF, Steele L, Fields P et al (1997) Cancer risks in two large breast cancer families linked to BRCA1 on chromosome 13q12-13. Am J Genet 61: 120-128
10. Ford D, Easton DF, Bishop DT, Narod SA and Goldgar DE (1994) The breast cancer linkage consortium. Risks of cancer in BRCA1 mutation carriers. Lancet 343 692-695
11. Futreal PA, Cochran C, Rosenthal J, et al (1994) Isolation of a diverged homeobox gene, MOX1, from the BRCA1 region on 17q21 by solution hybrid capture. Hum Mol Genet 3: 1359-1364
12. Gittes RF (1991) Carcinoma of the prostate. N Engl J Med 324: 236-245
13. Greer CE, Peterson SL, Kiviat NB and Manos MM (1991) PCR amplification from paraffin embedded tissues. Am J Clin Pathol 95: 117-124
14. Hubert A, Peretz T, Manor O, Kaduri L, Wienberg N, Lerer I, Sagi M and Abeliovich D (1999) The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet 65: 921-924
15. Issacs SD, Kiemeney LALM, Baffoe-Bonnie A, Beaty TH and Walsh PC (1995) Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 87: 991-996
16. Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, Eiriksdottir G, Johannsson OT, Borg A, Ingvarsson S, Easton DF, Egilsson V and Barkardottir RB (1996) High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56: 3663-3665
17. Knudson AG (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823
18. Langston AA, Stabford JL, Wicklund KG, Thompson JD, Blazej RG and Ostrander EA (1996) Germ-line BRCA1 mutations in selected men with prostate cancer. Am J Hum Genet 58: 881-885
19. Lehrer S, Fodor F, Stock RG, Stone NN, Eng C, Song HK and McGovern M (1998) Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. Br J Cancer 78: 771-773
20. Melamed J, Einhorn JM and Ittmann MM (1997) Allelic loss on chromosome 13q in human prostate carcinoma. Clin Cancer Res 3: 1867-1872
21. Schneider NR, Chaganti SR, German J and Chagnti RSK (1983) Familial predisposition to cancer and age at onset of disease in randomly selected cancer patients. Am J Hum Genet 35: 454-467
22. Sellers TA, Potter JD, Rich SS, Drinkard CR, Bostick RM, Kushi LH, Zheng W and Folsom AR (1994) Familial clustering of breast and prostate cancers and risk for postmenopausal breast cancer. J Natl Cancer Inst 86: 1860-1865
23. Sheldon DN, Williams M and Fraley EE (1980) Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 124: 626-631
24. Sigurdsson K, Thorlacius S, Tomasson J et al (1997) BRCA1 mutation in Icelandic prostate cancer patients. J Mol Med 75: 758-761
25. Struewing JP, Haitge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408
26. Tulinius H, Egilsson V, Olatsdottir GH and Sigvaldason H (1992) Risk of prostate, ovarian and endometrial cancer among relatives of women with breast cancer. Br Med J 305: 853-857
27. Watanabe M, Shiraishi T, Muneyuki T, Nagai M, Fukutome K, Murata M, Kawamura J and Yatani R (1998) Allelic loss and microsatellite instability in prostate cancers in Japan. Oncology 55: 569-574
28. Whittemore AS, Wu AH, Kolonel AN, John EM, Gallagher RP, Howe GR, West DW. The CZ and Stamey T (1995) Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 141: 732-740
29. Wilkens EP, Freije D, Xu J, Nusskern DR, Suzuki H, Isaacs SD, Wiley K, Bujnovsky P, Meyers DA, Walsh PC and Isaacs WB (1999) No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer. Prostate 39: 280-284
30. Williams BJ, Jones E, Zhu XL, Steele MR, Stephenson RA, Rohr LR and Brothman AR (1996) Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer. J Urol 155: 720-725